Reply to 'Not credible: A subversion of science by the pharmaceutical industry. Commentary on A global comparison regarding patient access to cancer drugs (Annals of Oncology 2007, vol 18, Suppl 3, pp1-75)' by Michel P Coleman

Download

Full text for this resource is not available from the Research Repository.

Export

Jönsson, B, Lichtenberg, Frank and Wilking, N (2007) Reply to 'Not credible: A subversion of science by the pharmaceutical industry. Commentary on A global comparison regarding patient access to cancer drugs (Annals of Oncology 2007, vol 18, Suppl 3, pp1-75)' by Michel P Coleman. Annals of Oncology, 18 (9). 1585 - 1587. ISSN 0923-7534

Abstract

Letter to the editor in response to: Not credible: A subversion of science by the pharmaceutical industry. Commentary on A global comparison regarding patient access to cancer drugs / Michel P Coleman, Annals of Oncology, vol 18, Suppl 3, pp. 1-75, 2007.

Dimensions Badge

Altmetric Badge

Item type	Article
URI	https://vuir.vu.edu.au/id/eprint/31729
DOI	10.1093/annonc/mdm397
Official URL	http://annonc.oxfordjournals.org/content/18/9/1585...
Subjects	Historical > FOR Classification > 1112 Oncology and Carcinogenesis Historical > Faculty/School/Research Centre/Department > College of Business
Keywords	patient access; cancer drugs; national cancer drug licensing; eISSN 1569-8041
Citations in Scopus	2 - View on Scopus
Download/View statistics	View download statistics for this item